✦ LIBER ✦

The treatment of depressive disorders in epilepsy: What all neurologists should know

✍ Scribed by Kanner, Andres M.

Book ID: 121377590
Publisher: Wiley (Blackwell Publishing)
Year: 2013
Tongue: English
Weight: 111 KB
Volume: 54
Category: Article
ISSN: 0013-9580
DOI: 10.1111/epi.12100

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Introduction-Treatment of psychiatric di

Introduction-Treatment of psychiatric disorders in adults with epilepsy: What every epileptologist should know

✍ Mula, Marco; Kanner, Andres M. 📂 Article 📅 2013 🏛 Wiley (Blackwell Publishing) 🌐 English ⚖ 30 KB

Racial/ethnic disparities in the treatme

Racial/ethnic disparities in the treatment of epilepsy: What do we know? What do we need to know?

✍ Magdalena Szaflarski; Jerzy P. Szaflarski; Michael D. Privitera; David M. Ficker 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 289 KB

The role of tumor necrosis factor-alpha

The role of tumor necrosis factor-alpha and other cytokines in depression: what dermatologists should know

✍ Kannan, Swati; Heller, Misha M; Lee, Eric S; Koo, John YM 📂 Article 📅 2011 🏛 Informa plc 🌐 English ⚖ 159 KB

Changes in the treatment of inpatient hy

Changes in the treatment of inpatient hyperglycemia: What every nurse practitioner should know about the 2012 Standards of Care

✍ Michele H. Talley; Alethea Hill; Laura Steadman; Mary Annette Hess 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 504 KB

How long should a trial of escitalopram

How long should a trial of escitalopram treatment be in patients with major depressive disorder, generalised anxiety disorder or social anxiety disorder? An exploration of the randomised controlled trial database

✍ David S. Baldwin; Dan J. Stein; Ornah T. Dolberg; Borwin Bandelow 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 130 KB 👁 2 views

## Abstract ## Objective To extend the knowledge of course of improvement in patients with major depressive disorder (MDD), social anxiety disorder (SAD) or generalised anxiety disorder (GAD) participating in randomised placebo‐controlled trials (RCTs) and to infer the optimal duration of initial

P.2.c.003 All for one or one for all - a

P.2.c.003 All for one or one for all - assessing the true treatment effect of active vs placebo therapy in severe major depressive disorder

✍ M.E. Thase; S.H. Kennedy 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 63 KB